Furthermore, hypokalaemia causes alterations in the levels of vasoactive mediators: an increase in vasoconstrictor stimuli (ACE, ET-1 and subtype B α-adrenergic receptors) and a reduction in vasodilatory stimuli (EDRF-1 and PGE2). The gene discussed is EDN1; the disease is Hypokalemia.